These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21617544)

  • 1. Probiotics in functional bowel disorders getting it right.
    Quigley EM
    J Clin Gastroenterol; 2011 Jul; 45(6):481-2. PubMed ID: 21617544
    [No Abstract]   [Full Text] [Related]  

  • 2. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
    Ringel-Kulka T; Palsson OS; Maier D; Carroll I; Galanko JA; Leyer G; Ringel Y
    J Clin Gastroenterol; 2011 Jul; 45(6):518-25. PubMed ID: 21436726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics in functional gastrointestinal disorders: what are the facts?
    Quigley EM
    Curr Opin Pharmacol; 2008 Dec; 8(6):704-8. PubMed ID: 18775516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
    Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
    Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of probiotics in the treatment of irritable bowel syndrome.
    Gaby AR
    Altern Ther Health Med; 2006; 12(1):17; author reply 17. PubMed ID: 16454141
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
    Williams EA; Stimpson J; Wang D; Plummer S; Garaiova I; Barker ME; Corfe BM
    Aliment Pharmacol Ther; 2009 Jan; 29(1):97-103. PubMed ID: 18785988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irritable bowel syndrome: the possible benefits of probiotics.
    Isselbacher KJ
    Postgrad Med; 2005 May; 117(5):7. PubMed ID: 15948360
    [No Abstract]   [Full Text] [Related]  

  • 9. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial.
    Sadrin S; Sennoune S; Gout B; Marque S; Moreau J; Zinoune K; Grillasca JP; Pons O; Maixent JM
    Dig Liver Dis; 2020 May; 52(5):534-540. PubMed ID: 31952938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of probiotics in the treatment of irritable bowel syndrome: two case reports.
    Faber S; Rigden S; Lukaczer D
    Altern Ther Health Med; 2005; 11(4):60-2. PubMed ID: 16053123
    [No Abstract]   [Full Text] [Related]  

  • 11. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics in irritable bowel syndrome: underachievers or underpowered?
    Ford AC
    Aliment Pharmacol Ther; 2010 Apr; 31(8):922-3; author reply 923-4. PubMed ID: 20415830
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome.
    Hong YS; Hong KS; Park MH; Ahn YT; Lee JH; Huh CS; Lee J; Kim IK; Hwang GS; Kim JS
    J Clin Gastroenterol; 2011; 45(5):415-25. PubMed ID: 21494186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome.
    Sinn DH; Song JH; Kim HJ; Lee JH; Son HJ; Chang DK; Kim YH; Kim JJ; Rhee JC; Rhee PL
    Dig Dis Sci; 2008 Oct; 53(10):2714-8. PubMed ID: 18274900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis.
    Wildt S; Munck LK; Vinter-Jensen L; Hanse BF; Nordgaard-Lassen I; Christensen S; Avnstroem S; Rasmussen SN; Rumessen JJ
    Inflamm Bowel Dis; 2006 May; 12(5):395-401. PubMed ID: 16670529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What you must know before you recommend a probiotic.
    Clauson ER; Crawford P
    J Fam Pract; 2015 Mar; 64(3):151-5. PubMed ID: 25789349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OTC product: VSL #3: the living shield.
    Scolaro KL
    J Am Pharm Assoc (2003); 2008; 48(6):e156. PubMed ID: 19019794
    [No Abstract]   [Full Text] [Related]  

  • 19. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R
    Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of oxygen in the viability of probiotic bacteria with reference to L. acidophilus and Bifidobacterium spp.
    Talwalkar A; Kailasapathy K
    Curr Issues Intest Microbiol; 2004 Mar; 5(1):1-8. PubMed ID: 15055922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.